The efficacy of intubation on adults lacrimal duct obstruction withnew generation silicon tube

中国实用眼科杂志 Pub Date : 2017-07-10 DOI:10.3760/CMA.J.ISSN.1006-4443.2017.07.011

Shaobo Zhou, Juan Tan, Yuyan Guo

{"title":"The efficacy of intubation on adults lacrimal duct obstruction withnew generation silicon tube","authors":"Shaobo Zhou, Juan Tan, Yuyan Guo","doi":"10.3760/CMA.J.ISSN.1006-4443.2017.07.011","DOIUrl":null,"url":null,"abstract":"Objective \nTo study the efficacy of intubation on adults lacrimal duct obstruction with new generation silicon tube. \n \n \nMethods \nA retrospective non-random and non-control case series. Thirty-two patients (37 eyes) with lacrimal duct obstruction who had undergone intubation with new generation silicon tube were retrospectively reviewed in Department of Ophthalmology, the First Affiliated Hospital of Guangzhou Medical University. The mean duration of symptoms of epiphora was 16.3±3.8 months. All the patients were followed up at least 3 months after the tube removal. Success rates were evaluated by both symptoms of epiphora and syringing. \n \n \nResults \nAmong 37 eyes, 26 of 37 (70.3%) were cured completely, 4 eyes were relieved in epiphora, 24 of 27 eyes (88.9%) were cured or relievedin simple lacrimal duct obstruction, 6 of 10 eyes (60.0%) was cured or relieved in dacryocystitis(P <0.05). The success rate for patients whose duration of symptoms of epiphora within 2 yearswas much higher thanthat whose duration of symptoms over 2 years(P <0.05). \n \n \nConclusions \nIt seems that the intubation using new generation silicon tube has a high success ratefor lacrimal duct obstruction, especially for early simple lacrimal duct obstruction. \n \n \nKey words: \nLacrimal duct obstruction; Dacryocystitis; Intubation","PeriodicalId":10236,"journal":{"name":"中国实用眼科杂志","volume":"138 1","pages":"704-707"},"PeriodicalIF":0.0000,"publicationDate":"2017-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国实用眼科杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1006-4443.2017.07.011","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Objective To study the efficacy of intubation on adults lacrimal duct obstruction with new generation silicon tube. Methods A retrospective non-random and non-control case series. Thirty-two patients (37 eyes) with lacrimal duct obstruction who had undergone intubation with new generation silicon tube were retrospectively reviewed in Department of Ophthalmology, the First Affiliated Hospital of Guangzhou Medical University. The mean duration of symptoms of epiphora was 16.3±3.8 months. All the patients were followed up at least 3 months after the tube removal. Success rates were evaluated by both symptoms of epiphora and syringing. Results Among 37 eyes, 26 of 37 (70.3%) were cured completely, 4 eyes were relieved in epiphora, 24 of 27 eyes (88.9%) were cured or relievedin simple lacrimal duct obstruction, 6 of 10 eyes (60.0%) was cured or relieved in dacryocystitis(P <0.05). The success rate for patients whose duration of symptoms of epiphora within 2 yearswas much higher thanthat whose duration of symptoms over 2 years(P <0.05). Conclusions It seems that the intubation using new generation silicon tube has a high success ratefor lacrimal duct obstruction, especially for early simple lacrimal duct obstruction. Key words: Lacrimal duct obstruction; Dacryocystitis; Intubation

查看原文本刊更多论文

新一代硅管插管治疗成人泪道梗阻的疗效观察

目的探讨新一代硅管插管治疗成人泪道梗阻的疗效。方法采用回顾性、非随机、非对照病例。回顾性分析了广州医科大学第一附属医院眼科行新一代硅管插管治疗泪道阻塞32例(37眼)的临床资料。症状的平均持续时间为16.3±3.8个月。所有患者在拔管后至少随访3个月。成功率评估两种症状的回眸和注射器。结果37眼全部治愈26眼(70.3%)，泪显缓解4眼，单纯性泪管梗阻治愈或缓解24眼(88.9%)，泪囊炎治愈或缓解6眼(60.0%)(P <0.05)。症状持续时间在2年以内的患者治疗成功率明显高于症状持续时间在2年以上的患者(P <0.05)。结论应用新一代硅管插管治疗泪道梗阻，成功率高，尤其对早期单纯性泪道梗阻疗效显著。关键词:泪道阻塞;泪囊炎;插管

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中国实用眼科杂志

自引率

0.00%

发文量

9101

期刊介绍： China Practical Ophthalmology was founded in May 1983. It is supervised by the National Health Commission of the People's Republic of China, sponsored by the Chinese Medical Association and China Medical University, and publicly distributed at home and abroad. It is a national-level excellent core academic journal of comprehensive ophthalmology and a series of journals of the Chinese Medical Association. China Practical Ophthalmology aims to guide and improve the theoretical level and actual clinical diagnosis and treatment ability of frontline ophthalmologists in my country. It is characterized by close integration with clinical practice, and timely publishes academic articles and scientific research results with high practical value to clinicians, so that readers can understand and use them, improve the theoretical level and diagnosis and treatment ability of ophthalmologists, help and support their innovative development, and is deeply welcomed and loved by ophthalmologists and readers.